IncFact
Company Profiles: Revenue, Growth, Competition

AGIOS PHARMACEUTICALS Revenue, Growth & Competitor Profile

DBA AGIOS
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Agios Pharmaceuticals

Access the complete profile.

Agios Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees500 - 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
541711 Research & Development in Biotechnology
Address88 Sidney St
Cambridge, MA 02139

www.agios.com
Note: Revenues for privately held companies are statistical evaluations.


Agios Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.


Agios Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Agios Pharmaceuticals Annual Revenue and Growth Rate

Agios Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Agios Pharmaceuticals's revenues are gauged from an analysis of company filings.



Agios Pharmaceuticals's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Agios Pharmaceuticals Revenue (Sales) Agios Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Agios Pharmaceuticals is developing and marketing. Agios Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
PYRUKYND
Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, PKD and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias
07/15/2019
AQVESME
Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, PKD and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias
07/15/2019
AQVYGO
Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, PKD and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias
07/15/2019

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Agios Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Agios Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Agios Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Agios Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM47 
CEPHALONFrazer, PA44 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 
COVANCEPrinceton, NJ27 




Nearby Competitors

These companies are similar in business line and location to Agios Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ALNYLAM PHARMACEUTICALSCambridge, MA100 
BLUEBIRD BIOCambridge, MA94 
BEIGENE USACambridge, MA64 
ARIAD PHARMACEUTICALSCambridge, MA59 
AGIOS PHARMACEUTICALSCambridge, MA53 
CENTOGENE USCambridge, MA44 




Future Competition: Agios Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Agios Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Agios Pharmaceuticals Competitors